Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kronos Bio, Inc. | 2,765,314 | 2,765,314 | 0 | 2,627 | 2,281 | 16.73% | -346 |
| Allogene Therapeutics, Inc. | 1,798,163 | 1,798,163 | 0 | 3,830 | 2,625 | 19.25% | -1,205 |
| Kyverna Therapeutics, Inc.(KYTX) | 4,523,924 | 4,523,924 | 0 | 16,919 | 8,731 | 64.02% | -8,188 |
| Dyne Therapeutics, Inc.(DYN) | 407,499 | 0 | -407,499 | 9,601 | 0 | — | -9,601 |
| Tectonic Therapeutics, Inc.(TECX) | 1,028,674 | 0 | -1,028,674 | 47,494 | 0 | — | -47,494 |
| Centessa Pharmaceuticals plc | 3,931,818 | 0 | -3,931,818 | 65,858 | 0 | — | -65,858 |